πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7439226

Serine protease inhibitors

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7439249

Inhibitors of phosphatases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7432290

Inhibitors of IMPDH enzyme

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7432242

Inhibitors of RGS proteins

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7427681

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7423049

Inhibitors of p38

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7419967

Sulfonamide inhibitors of aspartyl protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7414046

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7410981

Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7407962

Heteroaryl compounds useful as inhibitors or protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7407964

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7407939

Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetic

CureGenics Ltd. Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7405202

CRISP polypeptides as contraceptives and inhibitors of sperm capacitation

Regents of the University of Minnesota Β· Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7405302

5-lipoxygenase-activating protein (FLAP) inhibitors

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7399606

Methods for identifying IΞΊB Kinase (IKK) inhibitors

The Regents of the University of California Β· Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7390808

Inhibitors of GSK-3 and crystal structures of GSK-3Ξ² protein and protein complexes

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7390815

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7388002

Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases

BioCryst Pharmaceuticals, Inc. Β· Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7388017

Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7381825

Histone deacetylase inhibitors

Takeda San Diego, Inc. Β· Granted Tue Jun 03 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378403

Akt inhibitors, pharmaceutical compositions, and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378552

Monoamine re-uptake inhibitors and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378422

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7375079

Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus ne

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted